Wieder, Nechama
D’Souza, Elston N.
Martin-Geary, Alexandra C.
Lassen, Frederik H.
Talbot-Martin, Jonathan
Fernandes, Maria
Chothani, Sonia P.
Rackham, Owen J. L.
Schafer, Sebastian
Aspden, Julie L.
MacArthur, Daniel G.
Davies, Robert W.
Whiffin, Nicola http://orcid.org/0000-0003-1554-6594
Funding for this research was provided by:
Wellcome Trust (220134/Z/20/Z, 203141/Z/16/Z)
Royal Society (220134/Z/20/Z)
Rosetrees Trust (PGL19-2/10025)
Khoo Foundation
Article History
Received: 17 May 2023
Accepted: 15 April 2024
First Online: 29 April 2024
Declarations
:
: Not applicable
: Not applicable
: DGM is a paid advisor to GlaxoSmithKline, Insitro, Variant Bio and Overtone Therapeutics, and has received research support from AbbVie, Astellas, Biogen, BioMarin, Eisai, Google, Merck, Microsoft, Pfizer, and Sanofi-Genzyme. None of these activities are related to the work presented here. All other authors declare no conflicts of interest.